Clinical Trials Logo

Filter by:
NCT ID: NCT05592210 Recruiting - Clinical trials for Premature Infant Disease

Influence and Mechanism of Dyadic Coping on Parenting Stress and Parenting Self-Efficacy in Parents of Preterm Infant

Start date: March 16, 2023
Phase:
Study type: Observational

The goal of this observational study is to investigate the parenting stress, parenting self-efficacy and dyadic coping of preterm parents and explore the influence and pathway analysis of dyadic coping between parenting stress and parenting self-efficacy.

NCT ID: NCT05592197 Withdrawn - Clinical trials for Advanced Hepatocellular Carcinoma

Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

This is a multicentri prospective cohort study to investigate the safety and efficacy of external beam radiation (RT) combined with transarterial chemoembolization (TACE) and lenvatinib vs TACE and lenvatinib in the treatment of advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT).

NCT ID: NCT05592106 Completed - Liver Failure Clinical Trials

Gd-EOB-DTPA-enhanced T1 Map for Predicting Postoperative Liver Failure

Start date: October 10, 2021
Phase:
Study type: Observational

Researchers designed this study to compare the value of the conventional circular region-of-interest (ROI) and whole-liver histogram-based analysis on gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced T1 map for predicting postoperative liver failure (PHLF). Researchers collected and analyzed the data of patients who underwent partial hepatectomy for focal liver lesions. Researchers drew circular ROIs on Gd-EOB-DTPA-enhanced T1 maps to get the mean T1 values. Researchers used a multiparametric analysis software to get histogram parameters. Then researchers compared the differences of these parameters between the PHLF group and non-PHLF group.

NCT ID: NCT05592093 Recruiting - Clinical trials for Antioxidative Stress

Effect of Korean Red Ginseng on Oxidation in Middle-aged and Elderly Sub-health Population

Start date: March 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The objective of this study is to examine the effects and safety of Korean red ginseng capsule and placebo with middle-aged and elderly sub-health population.

NCT ID: NCT05592080 Completed - Clinical trials for Polycystic Ovary Syndrome

Exploring Liver and Muscle Fat Content Using MRI

Start date: October 1, 2021
Phase:
Study type: Observational

The aim of our study was to compare the difference of fatty infiltration in liver and muscle using magnetic resonance imaging (MRI) between overweight as well as obese polycystic ovary syndrome (PCOS) cases and body mass index (BMI)-matched women without PCOS, identifying the possible influence factors.

NCT ID: NCT05592054 Suspended - Clinical trials for Acute Ischemic Stroke

Proximal TEmporary oCclusion Using Balloon Guide Catheter for Mechanical Thrombectomy

PROTECT-MT
Start date: November 20, 2022
Phase: N/A
Study type: Interventional

A multi-center, prospective, randomized, open-label, blinded endpoint assessment (PROBE) clinical trial of endovascular treatment among selected AIS.

NCT ID: NCT05591885 Recruiting - Cognitive Function Clinical Trials

Nutrilite Memory Builder on the Improvement of Cognitive Function

Start date: October 24, 2022
Phase: N/A
Study type: Interventional

Its a randomized controlled trial, to evaluate the effect of NUTRILITE Memory Builder on the improvement of cognitive function in middle-aged and elderly people.

NCT ID: NCT05591144 Completed - Clinical trials for Tinnitus, Subjective

Short-term Oral Prednisone for Acute Subjective Tinnitus

STOP-FAST
Start date: October 30, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to investigate the efficacy of oral steroids in the acute tinnitus population. Participants will receive appropriate dosages of short-term prednisone and/or oral Ginkgo Biloba tablets.

NCT ID: NCT05590871 Recruiting - Hypertension Clinical Trials

FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension

Start date: March 31, 2023
Phase: N/A
Study type: Interventional

To verify the safety and effectiveness of the renal artery radiofrequency ablation system under the guidance of the three-dimensional cardiac electrophysiological mapping system in the renal denervation of essential hypertension.

NCT ID: NCT05590858 Completed - Clinical trials for Inflammation Vascular

Glycemic Control on Coronary Inflammation Evaluated by FAI in ACS

Start date: January 1, 2019
Phase:
Study type: Observational

This study aimed to clarify the relationship between blood glucose control and the FAI based pericoronary inflammation in low-risk ACS patients with or without diabetes. The results of this study are expected to provide evidence that quantitative assessment of pericoronary FAI helps monitor the local inflammatory activation in diabetic patients with poor glycemic control, therefore, pericoronary FAI evaluation, as a noninvasive imaging biomarker, plays an important role in early detecting coronary atherosclerosis risk in diabetes and allow timely providing appropriate risk reduction strategies in patients at high risk for future cardiovascular events.